Our data thus suggests that even though dual combination of MEK-JAK inhibition showed some degree of growth suppression (Fig. 4a), it does not impact on cancer stem cell contents; however, additional suppression of PDGFRβ is able to dramatically reduce this subpopulation. Here, MAP2K7 is linked to cancer.